Marshall Wace, LLP Pfizer Inc Call Options Transaction History

Marshall Wace, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $1.49 Million - $1.74 Million	-46,500 Reduced 79.49%	12,000 $398,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $6.32 Million - $7.32 Million	-175,100 Reduced 74.96%	58,500 $2.15 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $5.45 Million - $7.09 Million	138,300 Added 145.12%	233,600 $9.53 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $10.9 Million - $14.2 Million	-259,900 Reduced 73.17%	95,300 $4.89 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $9.92 Million - $12.1 Million	226,800 Added 176.64%	355,200 $15.5 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $4.49 Million - $5.32 Million	96,400 Added 301.25%	128,400 $6.73 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $9.52 Million - $11.8 Million	-208,100 Reduced 86.67%	32,000 $1.66 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $9.92 Million - $14.7 Million	240,100 New	240,100 $14.2 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.